Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Found 3454 publications
2014 Deep Research Report on Global and China Naltrexone HCL Industry US$ 2,200.00

2014 Deep Research Report on Global and China Naltrexone HCL Industry was professional and depth research report on Global Naltrexone HCL industry. The report firstly introduced Naltrexone HCL basic information included Naltrexone HCL definition classification application industry chain structure industry ...

Oct, 2014 138 pages
2014 Deep Research Report on Global and China Nalbuphine HCL Industry US$ 2,200.00

2014 Deep Research Report on Global and China Nalbuphine HCL Industry was professional and depth research report on Global and China Nalbuphine HCL industry. The report firstly introduced Nalbuphine HCL basic information included Nalbuphine HCL definition classification application industry chain ...

Oct, 2014 121 pages
Global and Chinese Vitamin A Palmitate Industry, 2009-2019 Market Research Report US$ 2,400.00

... . The report provides key statistics on the market status of the Vitamin A Palmitate manufacturers and is a valuable source of guidance and direction for ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Vitamin A Palmitate industry covering all important parameters ...

Oct, 2014 150 pages
Global and Chinese Vitamin A Acetate Industry, 2009-2019 Market Research Report US$ 2,400.00

... . The report then estimates 2014-2019 market development trends of Vitamin A Acetate industry. Analysis of upstream raw materials, downstream demand, and ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Vitamin A Acetate industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Insulin Pumps Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Insulin Pumps industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Insulin Needle Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Insulin Needle industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Insulin Lispro Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Insulin Lispro industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Insulin Glulisine Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Insulin Glulisine industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Insulin Glargine Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Insulin Glargine industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Insulin Detemir Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Insulin Detemir industry covering all important parameters ...

Oct, 2014 150 pages
Global and Chinese Insulin Degludec Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Insulin Degludec industry covering all important parameters. ...

Oct, 2014 150 pages
Global and Chinese Insulin Aspart Industry, 2009-2019 Market Research Report US$ 2,400.00

... capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, ... its feasibility. Overall, the report provides an in-depth insight of 2009-2019 global and Chinese Insulin Aspart industry covering all important parameters. ...

Oct, 2014 150 pages
Global ADHD Drugs Market 2014-2018 US$ 2,500.00

... hyperactivity, impulsiveness, and lack of focus and concentration. The causes of ADHD are not known. It is believed to be linked with genetic and environmental ... ADHD, which include: Stimulants Non-stimulants TechNavio's report, the Global ADHD Drugs Market 2014-2018, has been prepared based on an in-depth ...

Oct, 2014 80 pages
Insulin Market in China 2014-2018 US$ 2,500.00

... . It regulates the metabolism of glucose and other nutrients in the body. Insulin permits the body to utilize sugar (glucose) from carbohydrates in the ... sales of various second and third generation insulin products. TechNavio's report, Insulin Market in China 2014-2018, has been prepared based on an in-depth ...

Oct, 2014 78 pages
Global Drug Abuse Testing Market 2014-2018 US$ 2,500.00

... which are generally used in the diagnosis, treatment, and prevention of diseases. Drugs when used as medicines have positive effects on patients; however, some ... to screen sports athletes. TechNavio's analysts forecast the Global Drug Abuse Testing market to grow at a CAGR of 4.71 percent over the period 2013 ...

Oct, 2014 75 pages
Orphan Drug Market Access: Payer Insights on the Present and Future US$ 495.00

... stakeholders have valid interests which have to be addressed now. Orphan Drug Market Access: Payer Insights on the Present and Future offers insights ... cost, clinical data and involvement in the research process? Which future market developments may pose challenges? (ie: risk sharing, HTA assessment, a less ...

Oct, 2014
Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020 US$ 2,625.00

... drug candidate for EVD. Both these companies are developing their anti-ebola products under the contract of the U.S. department of defense (DoD). ... held in past years concerning the development of ebola viral disease therapeutics Pin-point analysis of geographic segments helps to identify opportunities for ...

Sep, 2014 55 pages
Pediatric Drugs Markets in China US$ 4,000.00

China's demand for Pediatric Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will ... environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and ...

Nov, 2014 195 pages
PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022 US$ 10,995.00

PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022 SUMMARY Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and ... pain market? What differences exist in the current disease management across the 3 NP indications, and across the 7 markets? What are the ...

Apr, 2014 423 pages
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2023 US$ 10,995.00

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2023 SUMMARY Major depressive disorder (MDD) is one of the most ... 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries ...

May, 2014 322 pages
PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update US$ 10,995.00

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update SUMMARY Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience ...

May, 2014 381 pages
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update US$ 10,995.00

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update SUMMARY Epilepsy is a brain disorder characterized by spontaneously occurring ... . Additional unmet needs still exists in terms of safety and efficacy. Will the drugs under development fulfil the unmet needs of the ...

Dec, 2013 306 pages
PharmaPoint: Asthma - US Drug Forecast and Market Analysis to 2023 US$ 4,995.00

PharmaPoint: Asthma - US Drug Forecast and Market Analysis to 2023 SUMMARY Asthma accounts for approximately 250,000 deaths around the world ... impact of key events as well the drivers and restraints affecting the US Asthma market. REASONS TO BUY Understand and capitalize by identifying products that ...

Aug, 2014 168 pages
PharmaPoint: Asthma - Japan Drug Forecast and Market Analysis to 2023 US$ 4,995.00

PharmaPoint: Asthma - Japan Drug Forecast and Market Analysis to 2023 SUMMARY Asthma accounts for approximately 250,000 deaths around the ... treatment with the ICS and ICS/LABA therapies. SCOPE Overview of Asthma including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines ...

Aug, 2014 167 pages
PharmaPoint: Asthma - Current and Future Players US$ 2,995.00

... Future Players SUMMARY GlobalData has released its pharma report, “PharmaPoint: Asthma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Asthma Market. The report identifies and analyses the key companies ...

Aug, 2014 55 pages
PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023 US$ 4,995.00

PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023 SUMMARY Asthma accounts for approximately 250,000 deaths around the world ... , this growth will be fueled mainly by the uptake of the new branded biologic drugs. A dip in sales caused by the Singulair patent expiry in 2012, as well as ...

Aug, 2014 183 pages
PharmaPoint: Asthma - 5EU Drug Forecast and Market Analysis to 2023 US$ 6,995.00

PharmaPoint: Asthma - 5EU Drug Forecast and Market Analysis to 2023 SUMMARY Asthma accounts for approximately 250,000 deaths around the ... the French, Spanish, and UK markets is attributable to the slightly decreasing prevalence of asthma in this country over the forecast period. . Advair’s active patent on ...

Aug, 2014 218 pages
Cough, Cold and Allergy (Hay Fever) Remedies in Algeria US$ 900.00

Rising disposable income levels supported sales growth in cough, cold and allergy (hay fever) remedies towards the end of the review ... domestic production struggling to meet demand. Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Algeria report offers a comprehensive guide to the ...

Sep, 2014 23 pages
Generic and Innovative Drugs Market in Ukraine 2014. Development Forecasts for 2014-2019. US$ 1,330.00

... procedures and upcoming changes or estimate demand or growth potential of this market – they will find the informational support needed in this valuable ... to launch a new business or add a new product line. Generic and innovative drugs market in Ukraine, development forecasts for 2014-2019 is typically ...

Aug, 2014 100 pages
Generic and Innovative Drugs Market in Russia 2014. Development Forecasts for 2014-2019. US$ 1,330.00

... and business consultants, as well as research specialists and analysts. Generic and innovative drugs market in Russia, Development forecasts for 2014-2019 is useful ... regulations (and impending changes) that apply to the manufacture and marketing of these new and sought after medicines. Discover what the ...

Aug, 2014 120 pages
Global Antibiotics Market 2014-2018 US$ 2,500.00

... , fungi, and parasites but are not effective against viruses. Antibiotics either block vital processes in bacteria, kill the bacteria, or halt ... , Phenicols, Quinolones, Sulfonamides, Tetracyclines, and Others. TechNavio's report, the Global Antibiotics Market 2014-2018, has been prepared based on an in-depth ...

Sep, 2014 96 pages
Tolvaptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and results This report covers: International Nonproprietary Name: Tolvaptan indications: Treatment of hypervolemic and euvolemic hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion and congestive heart failure innovator: Otsuka Pharm (Samsca); Aspen (Samsca) Country ...

Sep, 2014
Tolvaptan - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) US$ 1,400.00

... and results This report covers: International Nonproprietary Name: Tolvaptan indications: Treatment of hypervolemic and euvolemic hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion and congestive heart failure innovator: Otsuka Pharm (Samsca); Aspen (Samsca) Country ...

Sep, 2014
Tolvaptan - Comprehensive patent search US$ 6,200.00

... and results This report covers: International Nonproprietary Name: Tolvaptan indications: Treatment of hypervolemic and euvolemic hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion and congestive heart failure innovator:Otsuka Pharm (Samsca); Aspen (Samsca) Country ...

Sep, 2014
Simeprevir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and results This report covers: International Nonproprietary Name: Simeprevir indications: Treatment of chronic hepatitis C infection in combination with Peginterferon alfa and Ribavirin, or with Sofosbuvir and optionally Ribavirin innovator: Janssen Pharm (Olysio, Galexos) Country Coverage: ...

Sep, 2014
Simeprevir - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) US$ 1,400.00

... and results This report covers: International Nonproprietary Name: Simeprevir indications: Treatment of chronic hepatitis C infection in combination with Peginterferon alfa and Ribavirin, or with Sofosbuvir and optionally Ribavirin innovator: Janssen Pharm (Olysio, Galexos) Country Coverage: Albania ...

Sep, 2014
Mirabegron - Comprehensive patent search US$ 6,201.00

... , save searches and results This report covers: International Nonproprietary Name: Mirabegron indications: Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency innovator:Astellas (Myrbetriq, Betmiga) Country coverage: The In-depth search contains ...

Sep, 2014
Ledipasvir - Comprehensive patent search US$ 7,500.00

... searches and results This report covers: International Nonproprietary Name: Ledipasvir indications: Treatment of chronic HCV infection in combination with Sofosbuvir innovator:Gilead Country coverage: The In-depth search contains patents from territories that are individually verified and monitored ...

Sep, 2014
Elvitegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... results This report covers: International Nonproprietary Name: Elvitegravir indications: Treatment of HIV-1 infection in combination with Cobicistat, Emtricitabine and Tenofovir disoproxil fumarate, or Ritonavir-boosted protease inhibitors or other antiretrovirals innovator: Gilead (Stribild); Gilead ( ...

Sep, 2014
Elvitegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) US$ 1,400.00

... results This report covers: International Nonproprietary Name: Elvitegravir indications: Treatment of HIV-1 infection in combination with Cobicistat, Emtricitabine and Tenofovir disoproxil fumarate, or Ritonavir-boosted protease inhibitors or other antiretrovirals innovator: Gilead (Stribild); Gilead ( ...

Sep, 2014
Elvitegravir - Comprehensive patent search US$ 7,500.00

... This report covers: International Nonproprietary Name: Elvitegravir indications: Treatment of HIV-1 infection in combination with Cobicistat, Emtricitabine and Tenofovir disoproxil fumarate, or Ritonavir-boosted protease inhibitors or other antiretrovirals innovator:Gilead (Stribild); Gilead (Vitekta); ...

Sep, 2014
Aflibercept - Comprehensive patent search US$ 9,300.00

... of neovascular wet age-related macular degeneration; Treatment of macular edema following central retinal vein occlusion; Treatment of metastatic colorectal cancer that is resistant to or has progressed following an Oxaliplatin-containing regimen in combination with 5-Fluorouracil, Leucovorin and Irinotecan ...

Sep, 2014
Abatacept - Comprehensive patent search US$ 9,300.00

... indications: Treatment of adult rheumatoid arthritis, optionally in combination with DMARDs optionally other than TNF antagonists; Treatment of juvenile idiopathic arthritis, optionally in combination with Methotrexate; Treatment of juvenile rheumatoid arthritis innovator:Bristol Myers Squibb (Orencia) ...

Sep, 2014
Global Erectile Dysfunction Drugs Market 2014-2018 US$ 2,500.00

... and effective therapies. TechNavio's analysts forecast the Global Erectile Dysfunction Drugs market to decline at a CAGR of 4.47 percent over the period 2013- ... Surgery, Injection Therapies, and Testosterone Replacement Therapy. To calculate the market size, the report considers the revenue generated from the ...

Sep, 2014 77 pages
Pediatric Drug Development - Regulatory Challenges and Commercial Opportunities US$ 2,995.00

... Pediatric vaccines Key Reasons to Purchase Reviews the current regulatory landscape and helps sponsors to understand the potential impact of FDA SIA regulations ... plans; Identifies the key challenges associated with pediatric drug development and the ways to overcome these hurdles; Assesses what issues ...

Jul, 2014 64 pages
Adaptive Licensing - A Holistic Approach to Drug Development and Regulation US$ 2,995.00

... and registries. Data from ongoing RCTs, and the more robust data from post-license surveillance studies are used to determine full ... and political changes will be necessary to realize the full potential of AL. Scope Adaptive Licensing: Overview Introduction A Declining Industry – How AL can tackle issues ...

Jul, 2014 79 pages
Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities US$ 3,016.00

... of the drug development pipeline relating to Alzheimer's disease, which has been analysed alongside commercially available or developmental minimally-invasive AD diagnostics and ... studies involving AD patients (and those with (presumed) early-stage disease) and studies published over the last five year, 40,000 ...

Sep, 2014 185 pages
The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth US$ 900.00

... growth rate can be attributed to an increasing number of drugs being approved by the United States Food and Drug Association along with the increasing ... held a market share of ~% and recorded sales of USD ~ million. The US Anti Cancer Drug Market is expected to grow over the period at a CAGR of 29.4% with ...

Jul, 2014 144 pages
Drug Discovery Technologies - A Global Market Overview US$ 3,060.00

... field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Worldwide market for drug discovery technologies explored in this study includes Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, ...

Aug, 2014 248 pages
US CNS Disorders Drug Pipeline Insight 2014 US$ 2,400.00

... purchasing Hard Copy License depending on the location. The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry ... with launch of novel drugs will drive the growth of CNS disease market in future. “US CNS Disorders Drug Pipeline Insight 2014” Report ...

Aug, 2014 1700 pages
1 2 3 4 5 >
Skip to top